GlassScriptPhysician profile
Bruce B Mcintosh
NPI 1669451621
$435,153.91
in general payments reported to CMS, 2019-2025
15 companies · $61K in 2025
The $61K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82K · 2020: $50K · 2021: $63K · 2022: $71K · 2023: $59K · 2024: $48K · 2025: $61K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $110K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $27K · Travel and Lodging: $25K · Food and Beverage: $4,475 · Consulting Fee: $450 · Gift: $213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $110,470.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27,174.00 |
| Travel and Lodging | $25,466.46 |
| Food and Beverage | $4,475.29 |
| Consulting Fee | $450.00 |
| Gift | $213.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $314,784.11 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Medtronic, INC. | $56,797.28 | 2021-2025 | Absorbatack, Parietene Ds, Dextile |
| Davol INC. | $35,226.35 | 2019-2025 | Phasix Mesh, Bard 3dmax Mesh, Arista |
| Covidien LP | $27,176.96 | 2019-2020 | |
| Becton, Dickinson and Company | $635.89 | 2019-2025 | Bard 3dmax Mesh, Surgiphor, Phasix Mesh |
| Axogen | $135.42 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $113.71 | 2019 | |
| Tela Bio, INC. | $74.36 | 2022-2024 | Ovitex 2s |
| Ethicon US, LLC | $54.19 | 2019-2020 | |
| Conmed Corporation | $48.23 | 2022 | |
| Innovation Technologies INC | $35.91 | 2025 | Irrisept |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Innocoll Pharmaceuticals Limited | $19.49 | 2021 | |
| Acell, INC. | $16.88 | 2019 | |
| Celltrion USA INC. | $15.13 | 2025 | Vegzelma |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Mcintosh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.